Adagio Medical Holdings, Inc. (ADGM)
(Delayed Data from NSDQ)
$1.34 USD
-0.02 (-1.18%)
Updated Aug 7, 2025 03:59 PM ET
After-Market: $1.34 0.00 (-0.30%) 6:38 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ADGM 1.34 -0.02(-1.18%)
Will ADGM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADGM based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ADGM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Adagio Medical Holdings, Inc. GAAP EPS of -$0.51
Adagio Medical Reports First Quarter 2025 Results | ADGM Stock News
Adagio Medical to Present at the BofA Securities 2025 Health Care Conference | ADGM Stock News